May 3, 2023 – Brussels (International Covid Summit III)
Dr. David E. Martin (PhD, intellectual-property and patent expert) spoke at a non-official event held in a European Parliament meeting room and hosted by a small group of critical MEPs.
Martin argued that COVID-19 was not a natural pandemic but the result of decades of deliberate coronavirus research amounting to biological warfare and a financial heist. He presented a public-patent timeline: isolation of coronavirus as a modifiable model in 1965, early human trials (1967), animal adaptations, Pfizer’s 1990 spike-protein vaccine patent work, a 2002 UNC Chapel Hill “infectious replication defective” coronavirus patent (NIAID-funded), CDC’s 2003 SARS patent, gain-of-function exemptions, and pre-2019 language about “accidental or intentional release” of a respiratory pathogen. He claimed nature, science, and independent oversight had been hijacked since the 1960s and closed by calling for an end to all gain-of-function research, an end to weaponizing nature, and full product liability for corporations.
Core Narrative and Timeline Presented
Martin explained the events of 2019–2023 were not sudden or natural but the outcome of continuous work beginning in the mid-20th century. Key points from the speech (drawn from available transcripts) include:
- 1965: Coronavirus isolated as a pathogen model associated with the common cold and identified as suitable for modification.
- 1966: First transatlantic (U.S.–U.K.) biological experiment involving a coronavirus model.
- 1967: First human inoculation trials with modified coronavirus.
- 1970s: Creation of chimeric versions and adaptation to animals (pigs, dogs).
- 1990: Pfizer files a patent related to a spike-protein vaccine approach for coronavirus (initially tied to veterinary/industrial problems in dogs and pigs). Martin highlighted subsequent publications (1990–2018) concluding that coronaviruses mutate too rapidly for effective vaccines.
- 2002: University of North Carolina at Chapel Hill patents an “infectious replication defective clone of coronavirus,” work funded in part by NIAID (under Anthony Fauci). Martin interpreted the language as describing a targeted weapon-like construct and noted it preceded the 2003 SARS outbreak.
- 2003: CDC files a patent on SARS coronavirus isolated from humans (sequence obtained from China); Martin claimed this violated biological/chemical weapons treaties and that the patent was initially rejected before later issuance in 2007.
- 2005 onward: The pathogen platform is described in documents as a bioterrorism/bioweapon enabling technology. He referenced black-budget and dual biodefense/NIAID funding streams.
- 2014: Exemption from the U.S. gain-of-function research moratorium granted for certain University of North Carolina coronavirus work.
- 2016: Publication stating a SARS-related coronavirus (linked to Wuhan Institute of Virology material) was “poised for human emergence.”
- 2017–2019: Language in research and patent contexts referring to “accidental or intentional release of a respiratory pathogen.” Moderna patent applications in April 2019 allegedly modified to include such language as justification for vaccine work. September 2019 discussions of an impending infectious disease crisis to drive funding and acceptance of a “universal vaccine template,” with a target of worldwide acceptance by September 2020.
